retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide is a next-generation triple-pathway weight-loss drug that activates GLP-1, GIP, and at the same time. This combo reduces hunger, improves blood sugar, and increases fat burning by raising metabolism. In Triple Agonism Based Therapies for

In a Phase 2a trial specifically evaluating liver outcomes, retatrutide achieved an average 82% reduction in liver fat content

Tirzepatide is a dual incretin receptor agonist, meaning it activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor

Always measure in a well-lit area

How does the Precision Peptide Genetic Test help me choose the right medication

The doctor showed her how to administer the shot to herself and sent her home with a prescription for semaglutide

Based on the results of the SURMOUNT trial, Mounjaro will likely be the most effective obesity medication ever